Catalyst Wire Dossier Catalyst Wire Dossier

DAYBUE

trofinetide · Acadia Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DAYBUE, covering 2023-03-10 to 2026-03-27. Get the full timeline:

Most recent: FDA Approved: DAYBUE — Supplemental Application (Acadia Pharmaceuticals Inc.)

See pricing